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Cells translate extracellular signals into specific programs of gene expression that reflect their developmen-
tal history or identity. We present evidence that one way this interpretation may be performed is by cooperative
interactions between serum response factor (SRF) and certain homeodomain proteins. We show that human
and Drosophila homeodomain proteins of the paired class have the ability to recruit SRF to DNA sequences not
efficiently recognized by SRF on its own, thereby imparting to a linked reporter gene the potential to respond
to polypeptide growth factors. This activity requires both the DNA-binding activity of the homeodomain and
putative protein-protein contact residues on the exposed surfaces of homeodomain helices 1 and 2. The ability
of the homeodomain to impart signal responsiveness is DNA sequence specific, and this specificity differs from
the simple DNA-binding specificity of the homeodomain in vitro. The homeodomain imparts response to a
spectrum of signals characteristic of the natural SRF-binding site in the c-fos gene. Response to some of these
signals is dependent on the secondary recruitment of SRF-dependent ternary complex factors, and we show
directly that a homeodomain can promote the recruitment of one such factor, Elk1. We infer that SRF and
homeodomains interact cooperatively on DNA and that formation of SRF-homeodomain complexes permits the
recruitment of signal-responsive SRF accessory proteins. The ability to route extracellular signals to specific
target genes is a novel activity of the homeodomain, which may contribute to the identity function displayed by
many homeodomain genes.
Throughout development, cells respond to extracellular cues
with specific patterns of gene expression. The specificity inher-
ent in this process must reside at least in part in the nucleus,
because most cytoplasmic signal transduction pathways are
composed of ubiquitously expressed proteins shared by many
receptors. In Saccharomyces cerevisiae, for example, haploid
cells of opposite mating types interpret the activation of an
identical signal transduction pathway into distinct patterns of
gene expression (2, 38). This interpretation occurs at the level
of transcription by routing of the incoming signal to cell-type-
specific genes (54).
Similar information processing must occur in animal cells. In
Drosophila melanogaster, several receptor tyrosine kinases have
common signal transduction machinery but elicit different re-
sponses in the receiving cells (5, 12, 13; for a review, see
reference 41). In mammalian cells as well, both receptor ty-
rosine kinases and noncatalytic receptors of the cytokine class
use shared signal transduction pathways and transmit generic
signals that are differentially interpreted by the receiving cell.
For example, the nerve growth factor receptor, encoded by the
trk gene, induces terminal differentiation in PC12 cells, but it
induces mitogenesis in fibroblasts and meiotic maturation in
Xenopus oocytes (10, 39). Thus, distinct receptors elicit com-
mon intracellular signals that must be interpreted by the re-
ceiving cell in the context of its developmental history or iden-
tity.
How is generic signal transduction information interpreted
into a cell-type-specific program of gene expression? We have
proposed that this interpretation occurs by collaboration of
transcription factors of two classes—homeodomain and
MADS box proteins (19). Homeodomain proteins have roles
in establishing cell and segmental identity in animals and are
thought to exert this function by acting as transcription factors
(37, 51). MADS box proteins are less well understood at a
biological level. In plants, several genes of this class exhibit
homeotic functions in flower development (9, 50). Two rela-
tively well understood MADS box proteins, the yeast protein
encoded by the MCM1 gene and the mammalian serum re-
sponse factor (SRF), are transcription factors that link genes to
signal transduction pathways (59). Mcm1 is required for the
pheromone activation of cell-type-specific genes in yeast cells,
whereas SRF is required for the activation of the proto-onco-
gene c-fos and other immediate-early genes by growth factors
and cytokines. Both Mcm1 and SRF are known to interact with
proteins of the homeodomain family (19, 27). The physical
association of proteins of the homeodomain and MADS box
families is consistent with the idea that these proteins cooper-
ate to translate incoming signaling information into cell-type-
specific patterns of gene expression.
We previously described a genetic selection in yeast cells for
human cDNAs encoding proteins that cooperate with Mcm1 to
activate a cell-type-specific, pheromone-inducible reporter
gene in yeast cells (19). We isolated cDNAs encoding a novel
human paired class homeodomain protein, Phox1. We found
that Phox1 interacts in vitro with both Mcm1 and SRF. Phox1
enhances the binding of SRF to its cognate site in the c-fos
gene, the serum response element (SRE). Under in vitro con-
ditions with bacterially expressed proteins, the enhancement
was primarily kinetic and stable complexes of SRF and Phox1
were not detected. The enhancement activity resided within
the homeodomain of Phox1 and was shared with related
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D. melanogaster homeodomains, including those encoded by
the paired and orthodenticle genes. These results led us to
propose that one aspect of the identity function of homeodo-
mains may be the ability to route signals to cell-type-specific
genes and that homeodomains accomplish this by recruiting
MADS box proteins to these sites, thereby connecting cell-
type-specific genes to signal transduction pathways. Here we
have tested several predictions of this model. We find that
human and D. melanogaster homeodomain proteins can indeed
impart growth factor responsiveness to a reporter gene that is
unresponsive to signals in their absence. They apparently do
this by promoting the assembly of a multiprotein complex that
includes SRF and its signal-responsive accessory proteins.
MATERIALS AND METHODS
Plasmid constructions. For transient transfection assays in HeLa cells, the
reporter plasmid carried a single copy of the c-fos SRE positioned upstream of
a c-fos–chloramphenicol acetyltransferase fusion gene containing mouse c-fos
sequence from position 256 to 1109 (4, 16) (see Fig. 1A). A fragment of Phox1
encompassing amino acids 58 to 138 was expressed from the cytomegalovirus-
based vector pCGN (56). This fragment includes the Phox1 homeodomain, 18
N-terminal amino acids, and 2 C-terminal amino acids. In addition, the vector
incorporates an N-terminal extension with the sequence MASSYPYDVPD-
YASLGGPSRM, which includes the influenza virus hemagglutinin epitope tag
(underlined). Analogous 81-amino-acid fragments of the Drosophila Paired and
Deformed proteins were produced from the same vector.
The Elk1-VP16 expression vector was constructed by inserting the entire Elk1
cDNA (45) into a pCGN-based expression vector. This vector fuses to the N
terminus of Elk1, the influenza virus hemagglutinin epitope, the nuclear local-
ization signal of simian virus 40 large T antigen, and amino acids 411 to 490 of
the herpes simplex virus VP16 protein.
The SRF in vitro translation vector was pT7-ATG (40). The Phox1 cDNA was
inserted into the plasmid pT7bXBL (1), which expresses cDNAs under the
control of the T7 promoter and the human b-globin 59 untranslated region.
Site-directed mutagenesis of the Phox1 cDNA (31) was performed with single-
stranded DNA derived from the pCGN expression plasmids. The mutagenic
oligonucleotides were as follows (substitutions are underlined): pm1, 59-CTG
CAGGCTTTGGCGGCTGTCTTTGAG-39; pm2, 59-CGAGAAGACCTTGCC
GCGGCTGTGAACCTC-39; and pm3, 59-GATGCTTTTGTGCGAGCAG
CGCTTGCCCGC-39. The sequence encoding the N51Q mutant of Phox1 (i.e.,
with an N-to-Q change at residue 51) was excised from the previously described
GST fusion plasmid (19) as an XbaI-BamHI fragment and inserted into pCGN
in a fashion identical to that used for other pCGN constructs.
The variant SRE reporter genes were constructed by annealing the following
oligonucleotides [in which (A/T)6 refers to six positions that were synthesized
with an equimolar ratio of adenosine and thymidine precursors]: 59-AGCTTG
CATGCCTGCAGGTCGTCGGATGTCC(A/T)6GGACATCTG-39 and 59-TC
GACAGATGTCC(A/T)6GGACATCCGACGACCTGCAGGCATGCA-39. The
oligonucleotides were phosphorylated, annealed, and ligated into the c-fos–
chloramphenicol acetyltransferase reporter plasmid that had been cleaved with
HindIII and SalI to remove the wild-type SRE. The ligation products were
transformed into Escherichia coli, and transformants were grown as a pooled
population. Plasmid DNA was extracted from the pool and retransformed into E.
coli. Individual colonies were picked at random, and their plasmids were se-
quenced.
Transient-transfection assay. HeLa cells were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum (FBS). All trans-
fections were performed with calcium phosphate coprecipitation as described
previously (19). Cells were seeded on 10-cm-diameter plates and transfected at
30% confluence. Transfection cocktails contained 3 mg of reporter plasmid, 4.8
mg of Phox1 expression plasmid, unless otherwise indicated, and 0.1 mg of human
a-globin plasmid as an internal control for transfection efficiency. In all cases, the
total DNA concentration was adjusted to 20 mg with pUC119 DNA. The cells
were incubated with the transfection precipitates for 16 h, washed three times
with phosphate-buffered saline, and incubated for 24 h in Dulbecco’s modified
Eagle’s medium containing 0.5% FBS to achieve serum starvation. The serum-
starved cells were treated with serum-free Dulbecco’s modified Eagle’s medium
containing either no inducer, 15% FBS, 100 ng of phorbol myristate acetate
(PMA) per ml, 100 ng of epidermal growth factor per ml, 3 mM ionomycin, or a
FIG. 1. Phox1 and Paired confer serum inducibility on an SRE-containing
reporter gene. (A) Constructs used in the transfection assays. The reporter gene
carries a single copy of the c-fos SRE, with the sequence shown, inserted at the
SalI site immediately upstream of a truncated c-fos promoter carrying sequences
from 256 to 1109 (16). The sequences of the pm12 (15) and pm18 (17) mutants
are also shown. The expressor plasmid produces a Phox1 protein containing 18
amino acid residues N terminal and 2 residues C terminal to the 61-amino-acid
homeodomain. The influenza virus hemagglutinin epitope tag (HA) was fused to
the N terminus (see Materials and Methods for sequence). (B) HeLa cells were
transfected with a reporter gene containing either a wild-type c-fos SRE (lanes 1
to 12) or the pm12 mutant, which does not bind SRF (15) (lanes 13 to 16), and
either 1.2, 2.4, or 4.8 mg of an empty expression plasmid (V) or Phox1 expression
plasmid (P). Cells were starved for serum for 24 h and treated for 45 min with
serum-free medium (2) or medium containing 15% FBS (1). Cytoplasmic RNA
was isolated and analyzed by RNase protection assay, as described in Materials
and Methods. FOS represents correctly initiated transcripts from the reporter
gene, and a represents correctly initiated transcripts from the human a-globin
gene, which serves as an internal control for transfection efficiency. (C) HeLa
cells were transfected as described above with the wild-type SRE reporter gene
and the indicated amounts of expression vector producing Phox1 (lanes 2, 5, and
8), Paired (lanes 3, 6, and 9), or Deformed (lanes 4, 7, and 10) homeodomains.
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mixture of 10 mM forskolin and 0.5 mM isobutylmethylxanthine. After 45 min of
treatment, cells were harvested and resuspended in 200 ml of 10 mM Tris (pH
8.0)–150 mMNaCl. A 180-ml portion of this suspension was used to prepare total
cytoplasmic RNA (55), and a 20-ml portion was used to prepare whole-cell
extracts for DNA-binding assays and immunoblots.
RNase protection assays were performed as previously described (15, 19).
Aliquots of the final RNase protection products representing equal numbers of
transfected cells were analyzed on a first gel. Protected products on this gel were
quantitated with a Fuji BioImage analyzer. The remaining aliquots of the RNase
protection reaction mixtures were adjusted to normalize the signal from the
a-globin internal control and run on a second gel.
DNA-binding assays. For mobility shift assays of transfected cells, the 20-ml
aliquot of cell suspension was centrifuged, resuspended in 70 ml of immunopre-
cipitation (IP) buffer (0.1% Nonidet P-40, 25 mM HEPES (N-2-hydroxyeth-
ylpiperazine-N9-2-ethanesulfonic acid) [pH 7.9], 400 mM NaCl, 1 mM EDTA, 1
mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride), and sonicated twice
with 2-s pulses. The extracts were centrifuged for 20 min to remove cell debris,
and 2 ml of the supernatant was used in DNA-binding assays. Assays contained
10 mM Tris (pH 7.5), 50 mM NaCl, 1 mM dithiothreitol, 5% glycerol, and 50 mg
of poly(dI-dC) z (dI-dC) per ml. Assays of in vitro-translated proteins contained
1 ml of lysate in a 20-ml reaction mixture identical to the one described above,
except that it contained 5 mg of poly(dI-dC) z (dI-dC) per ml and 5 mg of bovine
serum albumin. The samples were further processed as described in reference 19.
RESULTS
The Phox1 and paired homeodomains confer response to
cellular signal transduction pathways on an SRE-containing
reporter gene in mammalian cells. In yeast cells, Phox1 acti-
vates a reporter gene under the control of three tandemly
repeated copies of the a-cell-specific, pheromone-inducible
upstream activation sequence (UAS) of the STE3 gene (19).
This UAS is normally bound cooperatively by a complex con-
taining the yeast MADS box protein Mcm1 and the product of
the mating type gene MATa1 (3, 26, 44). In the absence of a1,
Mcm1 does not bind to this site and reporter gene expression
is extinguished. Phox1 restored reporter gene expression, pre-
sumably by substituting for a1 and recruiting Mcm1 to the
reporter gene via a cooperative interaction. Biochemical anal-
ysis of extracts of yeast cells expressing Phox1 supports this
hypothesis (18).
To detect a similar interaction between Phox1 and SRF in
mammalian cells, we constructed a reporter gene carrying a
single copy of the c-fos SRE positioned upstream of a basal
c-fos promoter containing sequences from 256 to 1109 (Fig.
1A). Although this site confers serum responsiveness in its
natural promoter context, it imparts only weak constitutive
activity to the reporter gene in HeLa cells and in other cell
lines we have tested (Fig. 1B and data not shown). We spec-
ulate that SRF function in the natural c-fos promoter may
require cooperation with other elements missing from this
simplified promoter. If Phox1 were able to interact with SRF in
vivo and enhance its binding to the SRE as we observed in our
biochemical assays, then expression of Phox1 should impart
serum-inducible transcription to the reporter gene. To test this
prediction, we cotransfected the reporter gene into HeLa cells
with an expression vector that produced an 81-amino-acid frag-
ment of the Phox1 protein (Fig. 1A). This fragment encom-
passed the Phox1 homeodomain, 18 amino-terminal amino
acid residues, and 2 carboxy-terminal residues. In all experi-
ments, protein expression was verified by immunoblot or indi-
rect immunofluorescence with a monoclonal antibody directed
against an N-terminal epitope tag incorporated into the pro-
tein or by mobility shift assay of extracts (data not shown).
Following transfection, cells were starved for serum for 24 h
and then treated with 15% serum for 45 min. RNA was iso-
lated from the cells and analyzed by RNase protection for
correctly initiated transcripts arising from the reporter gene
and from a human a-globin plasmid used as an internal con-
trol.
Figure 1B shows that when the SRE-containing reporter
gene was cotransfected with an empty expression vector, it
directed the expression of low levels of mRNA that were not
significantly elevated by serum stimulation. In contrast, when
cotransfected with an expression vector producing the Phox1
homeodomain, the reporter became inducible by serum (Fig.
1B, lanes 4, 8, and 12). The degree of serum-induced transcrip-
tion of the reporter gene increased with the dose of Phox1
expression plasmid, suggesting that this assay responds to the
concentration and activity of Phox1 protein. We conclude that
the Phox1 homeodomain can impart serum responsiveness to
an SRE-containing reporter gene.
Phox1 is capable of binding directly to the c-fos SRE, albeit
with low affinity (19). To test whether Phox1 acted alone to
activate the reporter gene or required the cooperation of en-
dogenous cellular proteins such as SRF, we constructed a re-
porter that carries four nucleotide substitutions in the SRE
(pm12) (Fig. 1A). This mutation reduces the affinity of this
sequence for SRF by at least 2 orders of magnitude without
significantly affecting the binding of Phox1 (reference 15 and
data not shown). This mutant reporter was not activated by
Phox1 in vivo (Fig. 1B, lanes 15 and 16). Thus, binding of
Phox1 to DNA is not sufficient to impart serum inducibility
(see also Fig. 5). Rather, Phox1 requires the cooperation of
cellular proteins with DNA-binding specificity related to that
of SRF. These data, together with our previous observation
that Phox1 enhances the activation of this reporter gene by an
SRF-VP16 fusion protein (19), suggest that Phox1 interacts
with endogenous SRF in HeLa cells and recruits it to the
reporter gene in a functional form that enables the gene to
respond to serum growth factors.
We originally observed that the ability of the Phox1 homeo-
domain to enhance the binding of SRF to the SRE in in vitro
assays was shared with the D. melanogaster Paired (Prd) pro-
tein but not with more distantly related homeodomains (19).
To determine if this specificity was preserved in this in vivo
assay, we tested the Prd homeodomain and the distantly re-
lated homeodomain encoded by the Deformed (Dfd) gene.
Figure 1C shows that, like Phox1, Prd was able to impart serum
responsiveness to the SRE reporter gene in a dose-dependent
fashion. In contrast, Dfd was inactive. All three proteins were
expressed at equivalent levels in this experiment (data not
shown). Thus, the ability to impart serum responsiveness to
this gene is specific for certain homeodomains and does not
reflect a more general activity shared by all homeodomain
proteins. Moreover, this activity is conserved in a D. melano-
gaster segmentation gene product.
Phox1 enables the recruitment of SRF-dependent accessory
factors. As a further test of the hypothesis that Phox1 recruits
functional SRF to the reporter gene, we asked whether the
reporter gene adopted a pattern of signal responsiveness con-
sistent with the known functions of SRF in the c-fos promoter.
The c-fos SRE is sufficient for response to whole serum, puri-
fied polypeptide growth factors, and phorbol esters but not for
response to cyclic AMP (cAMP) or calcium ionophores (57).
Figure 2A (lanes 1 to 6) shows that the reporter gene exhibited
an identical pattern of responsiveness to these signals in the
presence of Phox1. It was induced by serum, epidermal growth
factor, and PMA but not by agents that elevate intracellular
cAMP or calcium. The reporter gene responded to none of
these signals in the absence of Phox1 (data not shown). Thus,
Phox1 imparts responsiveness to a subset of cellular signal
transduction pathways previously associated with SRF.
The ability of SRF to mediate a transcriptional response to
certain signal transduction pathways requires the recruitment
of signal-responsive ternary complex factors (TCFs), including
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the ets domain protein Elk1 (11, 17, 23, 24, 52). The TCFs do
not bind to the SRE on their own; instead, they recognize the
SRF-SRE complex, making additional DNA contacts to the 59
side of the SRF recognition site. Substitutions in these nucle-
otides prevent the recruitment of TCFs and abolish the re-
sponse of the SRE to some signal transduction pathways, par-
ticularly protein kinase C-dependent signals (17). If Phox1
imparts response to the protein kinase C activator PMA by
recruiting SRF and SRF in turn recruits TCFs, then activation
by PMA in the presence of Phox1 should depend on sequences
recognized by TCFs. To test this prediction, we assayed Phox1
on a reporter gene carrying an SRE mutant (pm18) (Fig. 1A)
that binds SRF but cannot recruit TCFs (17). Figure 2A (lanes
7 to 10) shows that Phox1 imparts to this reporter only a subset
of the responses observed with the wild-type sequence: re-
sponse to PMA was significantly reduced, whereas responses to
serum and epidermal growth factor were largely unaffected.
This pattern is consistent with the activity of the SRE in the
natural c-fos promoter and suggests that Phox1 recruits SRF to
the reporter in a configuration that allows SRF in turn to
recruit TCFs.
To measure directly the ability of Phox1 to effect the recruit-
ment of SRF-dependent accessory proteins, we constructed an
expression vector producing the Elk1 protein fused to the
transcriptional activation domain of VP16. Recruitment of
Elk1-VP16 to the SRE should activate the reporter gene even
in the absence of signals because of the constitutive activity of
the VP16 domain. Figure 2B shows that Elk1-VP16 elicited
weak but detectable activation of the reporter gene in serum-
starved cells in the absence of Phox1 (lane 3), suggesting that
the reporter retains a limited ability to bind endogenous SRF
in the absence of Phox1 and perhaps reflecting the ability of
Elk1 to interact cooperatively with SRF (49). In the presence
of Phox1, however, Elk1-VP16 strongly activated the reporter
gene, which is consistent with enhanced occupancy of the SRE
by SRF under these conditions. Thus, we conclude that Phox1
interacts cooperatively with SRF in vivo to enhance the binding
of SRF to the SRE. In the resulting complex, SRF retains the
ability to recruit at least one of its signal-responsive accessory
proteins.
Phox1 homeodomain function requires solvent-exposed
amino acid side chains. We used the serum response assay to
determine what portions of the Phox1 homeodomain were
required for its ability to recruit SRF to the SRE in vivo. We
originally found in our biochemical analysis that the ability of
Phox1 to enhance the binding of SRF to the SRE requires a
direct interaction between Phox1 and SRF (19). This observa-
tion predicts that the activity of Phox1 in vivo should require
amino acid side chains on the solvent-exposed surfaces of the
homeodomain (30). To test this prediction, we generated three
mutant Phox1 homeodomains, each carrying two amino acid
substitutions at positions predicted to lie on the solvent-ex-
posed surfaces of homeodomain helices 1 and 2, where they
could potentially contact other proteins. In all cases, the sub-
stitutions changed charged amino acid residues to alanines.
The mutants were tested for their ability to impart serum
responsiveness to the SRE reporter gene in HeLa cells. The
expression and activity of the mutant proteins were verified by
immunoblotting and mobility shift assays of transfected cell
extracts.
Figure 3 shows that the three mutants had significantly re-
duced activity in the reporter gene assay, suggesting that the
substituted amino acid residues were required for full activity
of the homeodomain in this assay. Mutant proteins 1 and 2
were expressed and bound DNA at levels equivalent to those
of wild-type Phox1 (data not shown). This observation suggests
that these proteins were properly folded in vivo and therefore
that the defect observed in this assay is likely due to a specific
requirement for the altered amino acid side chains. Mutant 3
was expressed at similar levels but had reduced activity on a
wild-type SRE probe, which carries a low-affinity Phox1-bind-
ing site, although it had wild-type activity on an SRE variant
that carries a high-affinity binding site. In view of the possible
reduction in the DNA-binding activity of mutant 3, we are
uncertain of the significance of the reduced activity of this
mutant in the reporter gene assay. Nevertheless, we conclude
that the amino acid side chains on helices 1 and 2 defined by
mutants 1 and 2, respectively, are required for the full activity
of the Phox1 homeodomain in imparting serum responsiveness
to the SRE reporter gene. On the basis of their predicted
positions on the homeodomain, we infer that these residues
are engaged in direct contact with SRF or another protein in
the complex that forms on the SRE.
Phox1 homeodomain function in vivo requires DNA-binding
activity. We found previously that the ability of the Phox1
homeodomain to interact with SRF in vitro and enhance the
kinetics of its binding to the SRE was not affected by an amino
acid substitution in helix 3 that abolished the DNA-binding
activity of the homeodomain. Although this observation sup-
ported the argument that protein-protein contacts must play a
predominant role in the SRF-Phox1 interaction under our in
FIG. 2. Phox1 confers response to growth factors and phorbol ester and
promotes recruitment of SRF-dependent ternary complex factors. (A) HeLa
cells were transfected with wild-type Phox1 expression plasmid and the wild-type
SRE reporter (lanes 1 to 6) or the pm18 mutant (lanes 7 to 10), which binds SRF
but does not recruit ternary complex factors (17). After serum starvation, the
transfected cells were treated for 45 min with serum-free medium supplemented
with nothing (lanes 1 and 7), 15% FBS (lanes 2 and 8), 100 ng of PMA per ml
(lanes 3 and 9), 100 ng of epidermal growth factor per ml (lanes 4 and 10), 10 mM
forskolin and 0.5 mM isobutylmethylxanthine (lane 5), and 3 mM ionomycin
(lane 6). RNA was isolated and analyzed by RNase protection assays. (B) HeLa
cells were cotransfected with the wild-type SRE reporter alone (lane 1), with 2.4
mg of Phox1 expression vector (lane 2), with 50 ng of expression vector producing
an Elk1-VP16 fusion protein (lane 3), or with both (lane 4). Cells were deprived
of serum for 24 h with no further treatment. Cytoplasmic RNA was isolated and
analyzed by RNase protection.
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vitro assay conditions, the lack of a requirement for Phox1
DNA-binding activity was surprising, since DNA binding is a
highly conserved activity of all homeodomains (51). It seemed
likely to us that DNA-binding activity would be important for
homeodomain function in vivo. Therefore, we tested the same
Phox1 DNA-binding mutant in our in vivo assay. This mutant
carries a substitution of glutamine for a conserved asparagine
common to nearly all homeodomains. In the engrailed home-
odomain, this asparagine side chain makes two hydrogen bond
contacts with an adenine base (28). Substitution of this residue
in the Phox1, Prd, and Bicoid homeodomains effectively abol-
ishes DNA-binding activity (11a, 19, 20).
Figure 4 shows that this mutant, N51Q, was unable to impart
significant serum responsiveness to the SRE reporter gene
(compare lanes 2 and 3). Western blotting (immunoblotting)
indicated that this protein was expressed at levels equivalent to
those of the wild type, and indirect immunofluorescence re-
vealed no difference in its subcellular localization (data not
shown). Thus, we conclude that under in vivo conditions the
DNA-binding activity of the Phox1 homeodomain is required
for the formation of active complexes at the SRE, even though
this activity is dispensable in vitro.
The activity of Phox1 in vivo is DNA sequence specific. If
homeodomain proteins impart specificity to incoming signals
by recruiting SRF, or related proteins, to cell-type-specific
genes, then Phox1’s activity in the serum response assay should
display DNA sequence specificity; that is, Phox1 should impart
serum responsiveness to only a subset of potential SRF-bind-
ing sites. To test this hypothesis, we made a series of mutations
in the c-fos SRE sequence. The SRE is a partially palindromic
sequence, containing at its center the sequence CCATATTA
GG. The flanking pairs of G z C base pairs are critical contact
sites for SRF at the SRE; they are found in essentially all
known SRF-binding sites (42, 58). We have focused our atten-
tion here on the AT-rich core of the SRE for two reasons.
First, this is the site of the Phox1 footprint in vitro (19). Sec-
ond, among many known and synthetic SRF-binding sites,
these six positions show a nearly absolute requirement for an
adenine or thymine base with relatively weak preferences for
either (42, 58). This observation suggests either that SRF does
not discriminate well between A z T and T z A base pairs in this
region or that the sequence of the AT core varies because it
also functions as a recognition site for other proteins.
Figure 5 shows assay results for a number of these variant
SREs. Figure 5A shows in vivo activities of variant SREs fol-
lowing serum stimulation in the absence and presence of
Phox1. All were essentially inactive in the absence of Phox1. In
the presence of Phox1, there was a dramatic range in the
degree of serum responsiveness, ranging from sites as strong as
or stronger than those of the wild type (e.g., pm102 [Fig. 5A,
lane 8] and pm104 [lane 12]) to sites nearly as weak as the
pm12 mutant, which does not bind SRF at all (e.g., pm106
[lane 14] and pm116 [lane 24]). Thus, all potential SRF-bind-
ing sites are not equally responsive to Phox1.
Figure 5B shows results of mobility shift assays of each of
these sites, with SRF produced by in vitro translation. These
assays indicated that the ability of Phox1 to impart serum
responsiveness to these sites in vivo correlated partially with
the affinity of the sites for SRF. For example, the three stron-
gest SRF-binding sites—wild-type, pm102, and pm104—were
all strongly serum responsive in the presence of Phox1. In
contrast, very poor SRF-binding sites exhibited weak serum
responsiveness in the presence of Phox1. This result is consis-
tent with the observation that the pm12 mutant, which fails to
bind SRF, is not activated by Phox1 (Fig. 1B). However, sev-
eral sites exhibited activities in vivo inconsistent with their
binding affinities in vitro. For example, pm58 and pm101
bound SRF with similar affinities (Fig. 5B, lanes 2 and 3), but
pm101 was a much more efficient SRE in the presence of
Phox1 (Fig. 5A, lanes 4 and 6). The pm113 site bound SRF
with lower affinity than pm116 (Fig. 5B, lanes 11 and 12) but
was a much stronger Phox1-dependent SRE in vivo (Fig. 5A,
lanes 22 and 24). pm106 bound SRF more strongly than either
pm103, pm107, or pm109, but it was a weaker Phox1-depen-
dent SRE than these sites. pm58, another weakly Phox1-de-
pendent site in vivo, bound SRF more strongly in vitro but
functioned less well in vivo than pm107, pm109, pm112, or
FIG. 3. Amino acid residues on the solvent-exposed surfaces of homeodo-
main helices 1 and 2 are required for maximal activity. The diagrams at the top
represent homeodomain helices 1 and 2 oriented so that homeodomain helix 3
and the DNA are down and the solvent is up. The amino acid residues in
boldface and joined by numbered bars are the residues replaced with alanines in
the indicated mutants. HeLa cells were transfected with the wild-type SRE
reporter with an empty expression vector (lane 1), vector expressing wild-type
(wt) Phox1 (lane 2), or vectors expressing the three Phox1 mutants (lanes 3 to 5).
Cells were starved for serum for 24 h and treated for 45 min with medium
containing 15% FBS. Cytoplasmic RNA was isolated and analyzed by RNase
protection assays. Protein expression was verified by immunoblotting and mo-
bility shift assays of aliquots of each transfection. All proteins were expressed at
equivalent levels. As discussed in the text, mutant 3 may have a mild defect in
DNA binding. Fos and a are as described for Fig. 1.
FIG. 4. Phox1 DNA-binding activity is required for activity in vivo. HeLa
cells were transfected with wild-type SRE reporter and empty expression vector
(lane 1), vector expressing wild-type Phox1 (lane 2), or vector expressing a
mutant Phox1 protein carrying an asparagine-to-glutamine substitution at posi-
tion 51 of the homeodomain. This mutation abolishes Phox1 DNA-binding
activity (19). Cells were starved for serum for 24 h and treated for 45 min with
medium containing 15% FBS. FOS and a are as described for Fig. 1.
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pm113. We conclude that the ability of an SRF-binding site to
respond to serum in the presence of Phox1 does not correlate
with its simple affinity for SRF in vitro. This observation sug-
gests that Phox1 modifies the binding specificity of SRF in vivo
and is consistent with the hypothesis that Phox1 can interact
cooperatively with SRF to recruit SRF to novel sites in vivo.
Results of binding assays for Phox1 are also shown in Fig.
5B. There was a marked lack of correlation between Phox1
binding affinity in vitro and Phox1-induced serum responsive-
ness in vivo. Two of the three high-affinity Phox1-binding sites,
pm58 and pm116, were poor SREs in the presence of Phox1.
The third high-affinity site, pm112, had moderate activity in
vivo. In contrast, the two strongest Phox1-dependent SREs in
vivo, pm102 and pm104, had little detectable affinity for Phox1
in vitro. Thus, the specificity of action of Phox1 in vivo differs
strikingly from its DNA-binding specificity in vitro, consistent
with the hypothesis that Phox1 acts in conjunction with other
cellular proteins to impart serum responsiveness to these re-
porter genes.
Taken together, these data support the hypothesis that SRF
and Phox1 interact cooperatively in vivo to impart to target
genes the ability to respond to extracellular signals. They do
this with a sequence specificity that is distinct from the simple
DNA-binding specificities of either protein alone. The data
support the idea that Phox1 and other Paired class homeodo-
main proteins have the ability to impart specificity to signal
transduction information by recruiting SRF and its signal-re-
sponsive accessory proteins to novel cell-specific DNA sites.
DISCUSSION
We originally isolated the Phox1 cDNA in a yeast genetic
screen for human cDNAs encoding proteins that could activate
a cell-type-specific, pheromone-inducible reporter gene in co-
operation with the yeast MADS box protein Mcm1 (19). Bio-
chemical studies using recombinant proteins showed that
Phox1 interacts with both Mcm1 and the closely related human
MADS box protein SRF. Here, we have shown that Phox1 has
a similar activity in human cells and can functionally recruit
SRF to a reporter gene carrying an SRF-binding site. The
effect of Phox1 in this assay is to enable this gene to respond to
growth factors.
Several lines of evidence support the interpretation that
Phox1 acts by recruiting SRF to the SRE-containing reporter
gene. First, the activity of Phox1 requires a site that can be
bound by SRF (Fig. 1B). Second, Phox1 confers on the re-
porter a spectrum of responses to extracellular signals charac-
teristic of natural SRF-binding sites (Fig. 2A). Third, Phox1
enables the recruitment of Elk1, a protein whose interaction at
the SRE is dependent on the presence of DNA-bound SRF
(Fig. 3B). Thus, we conclude that the Phox1 homeodomain and
the related D. melanogaster Prd homeodomain have the ability
to interact with SRF in vivo and recruit it to DNA sites that
SRF cannot activate on its own. Bringing SRF to the DNA in
turn allows the recruitment of signal-responsive accessory pro-
teins such as Elk1. Thus, the function of the homeodomains in
this assay is to connect these sites to cellular signal transduc-
tion pathways. The ability to specify the transcriptional re-
sponse to extracellular signals is a novel activity for the home-
odomain. We speculate that this activity may account for a
portion of the cell identity function displayed by many home-
odomains in animal development.
What is the nature of the SRF-homeodomain complex? The
effect of Phox1 on the binding of SRF to the SRE appears to
be principally kinetic in biochemical assays. Although this ef-
fect requires a direct interaction between the proteins, we do
not detect stable complexes containing both proteins under
standard mobility shift assay conditions, nor do we detect sta-
ble SRF-Phox1 complexes in solution in the absence of DNA.
How then does Phox1 enable the SRF-dependent activation of
our reporter genes? We envision three different models.
First, the effect of Phox1 on SRF binding in vivo may be
purely kinetic. Although genomic footprinting studies indicate
that SRF is constitutively bound at the SRE (22, 29), activation
might require the exchange of a new SRF molecule onto the
SRE in place of the molecule previously occupying the site.
Indeed, there is strong evidence for a growth factor-induced
phosphorylation of SRF that alters its kinetics of DNA binding
(47). Because the signals that act on the SRE are short-lived,
enhancing the rate of SRF exchange would increase the prob-
ability that a new SRF molecule arrives at the SRE while
signals are still active. Thus, SRF exchange could be the rate-
limiting step for activation of the SRE, and homeodomains
could act simply to accelerate this exchange reaction.
Second, Phox1 could act by eliciting a conformational
change in SRF molecules already bound at the SRE. This
conformational change would either permit the association of
signal-responsive accessory factors with SRF or enhance the
ability of SRF to interact with the basal transcription machin-
ery. Eliciting this conformational change would presumably
require a direct interaction between Phox1 and SRF as well as
at least transient association of Phox1 with DNA.
Third, SRF and Phox1 could form stable cooperative com-
plexes on DNA. This is the model we favor for several reasons.
In yeast cells, Phox1 functionally replaces the a1 protein at the
FIG. 5. Phox1 imparts serum responsiveness in a sequence-specific fashion.
(A) Variant SRE reporter genes with the core sequences shown were transfected
into HeLa cells with empty expression vector (2) or Phox1 expression vector
(1). All cells were serum starved for 24 h and treated for 45 min with medium
containing 15% FBS. (B) Human SRF produced by in vitro translation was
assayed by mobility shift on probes derived from each of the variant SREs (upper
gel). The probes were prepared by PCR amplification of the corresponding
reporter gene plasmids with a common pair of end-labeled primers, generating
a set of probes with identical specific activity. Only a portion of the gel is shown.
The Phox1 homeodomain fragment corresponding to the protein expressed in
the transfection experiments was produced by in vitro translation and assayed as
described for SRF (lower gel).
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STE3 UAS, where a1 clearly interacts cooperatively with
Mcm1 (3, 26, 44). Presumably, therefore, Phox1 is also able to
interact cooperatively with Mcm1. Indeed, in extracts of yeast
cells expressing Phox1, we detect a stable complex on an STE3
probe that contains both Phox1 and Mcm1 (18). Formation of
this complex is required for reporter gene activation. In con-
trast, we do not observe the formation of this stable complex
using purified Phox1 and Mcm1 produced in bacteria. Instead,
under these conditions, Phox1 elicits a purely kinetic effect on
Mcm1 binding, as we had observed with SRF. Thus, the for-
mation of stable Phox1-Mcm1 complexes must require a com-
ponent missing from our purified preparations. We have iden-
tified an activity in yeast extracts that permits the formation of
stable complexes of recombinant Phox1 and Mcm1 (18), which
is consistent with this hypothesis. A similar activity may exist in
HeLa cells.
A second reason we favor the hypothesis that stable SRF-
Phox1 complexes are required to activate reporter genes in
vivo is that the sequence specificity of reporter gene activation
in vivo is distinct from the binding specificity displayed by SRF
in vitro. If Phox1 were simply accelerating the kinetics of SRF-
DNA association or inducing a conformational change in SRF
already bound to DNA, there would be a strict correlation
between reporter gene activity in vivo and SRF affinity in vitro.
Instead, by altering the apparent sequence specificity of SRF in
vivo, Phox1 must be differentially altering the equilibrium
binding constant of SRF at each sequence. The most likely way
it could do so is by interacting cooperatively with SRF at
selected sites. The degree of cooperativity presumably depends
on stereospecific contacts between Phox1 and SRF and be-
tween Phox1 and DNA.
What is the organization of these putative SRF-Phox1 com-
plexes? On the basis of the results presented here, we can
make several inferences about their physical organization.
First, complex formation requires SRF-DNA contact, because
sites that are not bound by SRF cannot be activated by Phox1
(Fig. 1B and 5). Second, complex formation requires home-
odomain-DNA contact, because a mutant homeodomain that
cannot bind DNA cannot activate the SRE (Fig. 4). Third,
complex formation requires contact between the Phox1 home-
odomain and another cellular protein, possibly SRF, because
full activity of the homeodomain requires amino acid side
chains predicted to be oriented away from the DNA (Fig. 3).
Fourth, the sites on SRF contacted by Phox1 are likely to be
distinct from the sites contacted by Elk1, since a complex
containing all three proteins can apparently assemble on the
SRE (Fig. 2). However, confirmation of these inferences will
require biochemical analysis of these complexes.
Implications for the biochemical function of the homeodo-
main. In D. melanogaster, the specificity of action of homeotic
genes resides within the homeodomain of the encoded proteins
(14, 32, 36). But these proteins are closely related in sequence,
and their DNA-binding specificities in vitro are nearly identi-
cal. Furthermore, the amino acid residues responsible for the
different biological activities of two homeodomains that have
been identified are largely residues that do not contact DNA in
the binary complex (7, 34, 65). For the pair-rule gene fushi
tarazu, the DNA-binding specificity of the homeodomain is
also insufficient to explain all of the gene’s activities in vivo
(48). Therefore, the simple DNA-binding specificity of most
homeodomains observed under in vitro conditions is not sufficient
to explain the biological activity of the corresponding genes.
The relatively degenerate DNA recognition specificity dis-
played by homeodomains has led many investigators to pro-
pose that homeodomains must act in conjunction with other
proteins in vivo (21). Several examples of protein-protein in-
teractions involving homeodomains have now been reported.
One common theme is direct interaction between two homeo-
domains, including the yeast homeodomain proteins a1 and a2
(25, 35), the a1-related D. melanogaster Extradenticle protein
and the homeotic gene products (6, 46, 60), the Caenorhabditis
elegans homeodomain proteins mec-3 and unc-86 (63), and the
human HOXD8 and HOXD9 proteins (64). A distinct exam-
ple of homeodomain-homeodomain interaction is the cooper-
ative homodimer formation observed with paired class homeo-
domains (62).
Homeodomains also interact with other proteins. The yeast
a2 homeodomain interacts with Mcm1, forming cooperative
protein-DNA complexes on highly specific operator sites (27,
53). This interaction contributes to the determination of cell
identity in yeast cells. Nevertheless, although Mcm1 and SRF
are closely related proteins, the biochemical details of the
Mcm1-a2 interaction differ significantly from those of the
SRF-Phox1 interaction, showing a dependence on sequences
that are N terminal to the homeodomain rather than on the
homeodomain itself (61). The SRF-Phox1 interaction is more
similar to the interaction of the POU homeodomain protein
Oct-1 with the viral transactivator VP16. The interaction of
Oct-1 and VP16, like that of Phox1 and SRF, depends on
amino acid residues on the exposed surfaces of helices 1 and 2
of the homeodomain, although the precise positions of appar-
ent contact differ (33, 43). Second, the effect of the Oct-1-VP16
interaction is the recruitment of both proteins to sites that
neither protein binds efficiently without its partner (8); that is,
the complex binds DNA with specificity which is distinct from
that of the individual components, as we observe with SRF and
Phox1.
SRF-homeodomain interactions and the specificity of signal
transduction to the nucleus. The ability of homeodomains to
interact with SRF could account for some of the biological
activities of homeodomain genes in development. These genes
have a variety of roles in imparting positional identity and
ultimately cellular identity in organisms ranging from yeasts to
vertebrates (37). The determination of cellular identity must
be intimately related to the ability of a cell to respond to
extracellular signals. We propose that homeodomains may im-
part identity to a cell by directly programming the transcrip-
tional response of the cell to inductive signals. Our molecular
data suggest that homeodomains can do this by recruiting
proteins of the MADS box family, such as SRF, to novel DNA
sites. Because SRF in turn recruits a set of signal-responsive
accessory proteins, homeodomains may physically link these
new genes to the cell’s signal transduction machinery. Speci-
fying the primary transcriptional response to an inductive sig-
nal may be the critical step in defining the developmental fate
of a cell.
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